Neonatal rheumatic disorders. View of the pediatrician.
Publication/Presentation Date
5-1-1989
Abstract
Neonatal lupus is a unique clinical entity characterized primarily by cutaneous or cardiac injury. Dermatitis usually resolves without significant residual effects but heart block may be irreversible and life threatening during the neonatal period. SS-A/Ro and/or SS-B/La antibodies of maternal origin are present in the serum of the mother and affected infant and are markers for this syndrome. For many mothers breast feeding is the preferred choice for infant nutrition. With proper guidance, lactating mothers may safely use several antirheumatic medications such as ibuprofen, piroxicam, flurbiprofen, diclofenac, mefenamic acid, prednisone, sulfasalazine, and methotrexate.
Volume
15
Issue
2
First Page
287
Last Page
305
ISSN
0889-857X
Published In/Presented At
Goldsmith D. P. (1989). Neonatal rheumatic disorders. View of the pediatrician. Rheumatic diseases clinics of North America, 15(2), 287–305.
Disciplines
Medicine and Health Sciences | Pediatrics
PubMedID
2657891
Department(s)
Department of Pediatrics
Document Type
Article